N/A
ID
Bron
Verkorte titel
Aandoening
gingivitis
Ondersteuning
Regulatory and Clinical Development
8700 Mason-Montgomery Road
Mason, OH 45040
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Bleeding on Marginal Probing (BOMP) – Angular Bleeding Index (Van der Weijden 1994).<br>
This score will be done on day 0, day 21, week 1, week 2 en week 4. <br>
The gingiva is lightly dried with compressed air and lightly probed with a probe. The probe is inserted into the gingival crevice to a depth of approximately 2mm or until slight resistance is felt. The probe is run gently along the marginal gingival holding the probe at a an angle of approximately 60 degrees to the longitudinal axis of the tooth and in contact with the sulcular epithelium. Minimum axial force is used to avoid undue penetration in the tissue. The probe is moved around the crevice gently stretching the epithelium. A bleeding score is given to six gingival areas of the tooth. These are the disto-vestibular, vestibular, mesio-vestibular, disto-lingual, lingual and the mesio-lingual regions.
Achtergrond van het onderzoek
The study is designed as a two treatment, examiner-blind, randomized, experimental gingivitis, split-mouth design study. A 3-week non-brushing period (experimental gingivitis) will be introduced to standardize the level of gingivitis inflammation at the start of the actual experiment. This model will assess the reduction of gingivitis after this 3-week experimental gingivitis (EG) period comparing 2 manual brushes in a split-mouth design.
Doel van het onderzoek
N/A
Onderzoeksopzet
- Familiarization Phase
The familiarization phase will last approximately 20 days.
- Experimental Gingivitis Phase
The experimental phase will last 21 days.
- Healing Phase
The healing phase will last 4 weeks
Onderzoeksproduct en/of interventie
Familiarization Phase:
-Brushing 2x a day 2 minutes: Crest Cavity Protection toothpaste in combination with on alternate days the Oral-B CrossAction ProHealth manual toothbrush or Oral-B Advantage 123 manual toothbrush.
-Using interdental cleaners 2x a day
The familiarization phase will last approximately 20 days.
Experimental Gingivitis Phase
Subject are instructed to refrain from brushing the lower jaw for the next 21 days, during which time they brush their upper jaw on alternate days with one of the two brushes to further familiarization.
-Brushing 2x a day 2 minutes in the upper jaw: Crest Cavity Protection toothpaste in combination with on alternate days the Oral-B CrossAction ProHealth manual toothbrush or Oral-B Advantage 123 manual toothbrush.
The experimental phase will last 21 days.
Healing Phase:
Brushing 2x a day:Crest Cavity Protection toothpaste in combination with the Oral-B CrossAction ProHealth manual toothbrush and Oral-B Advantage 123 manual toothbrush.
This is according to a split mouth design, whereby either the right or left side of the mouth being brushed for a period of one (1) minute per side with either the CrossAction ProHealth manual toothbrush or the Advantage 123 manual toothbrush, and the opposing side for 1 extra minute with the alternative brush, as randomly assigned.
The healing phase will last 4 weeks.
Publiek
Afdeling CPT- Parodontologie<br>
Gustav Mahlerlaan 3004
G.A. Weijden, van der
Amsterdam 1081 LA
The Netherlands
+31 (0)20 5188307
ga.vd.weijden@acta.nl
Wetenschappelijk
Afdeling CPT- Parodontologie<br>
Gustav Mahlerlaan 3004
G.A. Weijden, van der
Amsterdam 1081 LA
The Netherlands
+31 (0)20 5188307
ga.vd.weijden@acta.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Be between the ages of 18 and 70
2. Be in good general health as determined by the investigator/designee based on a review of the medical history/update
3. Possess at least 5 evaluable teeth in each quadrant in the lower jaw
4. Be a non-smoker
5. Have a > 25% level of bleeding
6. Be right handed
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Orthodontic banding or wires or partial dentures
2. Severe periodontal disease (no sites with PPD > 5mm), including but not limited to purulent exudate, generalized mobility, and or severe recession
3. Any disease or conditions that could be expected to interfere with examination procedures or the subject safely completing the trial.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL1188 |
| NTR-old | NTR1233 |
| Ander register | MEC : 07/313 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |